A Delphi Survey Study to Formulate Statements on the Treatability of Inherited Metabolic Disorders to Decide on Eligibility for Newborn Screening

• Main Authors: Abigail Veldman (Author), M. B. Gea Kiewiet (Author), Dineke Westra (Author), Annet M. Bosch (Author), Marion M. G. Brands (Author), René I. F. M. de Coo (Author), Terry G. J. Derks (Author), Sabine A. Fuchs (Author), Johanna. M. P. van den Hout (Author), Hidde H. Huidekoper (Author), Leo A. J. Kluijtmans (Author), Klaas Koop (Author), Charlotte M. A. Lubout (Author), Margaretha F. Mulder (Author), Bianca Panis (Author), M. Estela Rubio-Gozalbo (Author), Monique G. de Sain-van der Velden (Author), Jaqueline Schaefers (Author), Andrea B. Schreuder (Author), Gepke Visser (Author), Ron A. Wevers (Author), Frits A. Wijburg (Author), M. Rebecca Heiner-Fokkema (Author), Francjan J. van Spronsen (Author)
• Format: Book
• Published: MDPI AG, 2023-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The Wilson and Jungner (W&J) and Andermann criteria are meant to help select diseases eligible for population-based screening. With the introduction of next-generation sequencing (NGS) methods for newborn screening (NBS), more inherited metabolic diseases (IMDs) can technically be included, and...